Vanderbilt’s partnership with Deerfield Management, Ancora, is opening a new request for applications focused on rare genetic diseases in January 2021.
Faculty interested in this rolling submission-review opportunity are invited to attend an information session, “Accelerating the Commercialization of Transformative Biomedical Technologies with a Focus on Rare Genetic Diseases,” on Thursday, Jan. 21, at 10 a.m. CT. More information is available here.